VAR2CSA Serology to Detect Plasmodium falciparum Transmission Patterns in Pregnancy.
Adult
Antibodies, Protozoan
/ immunology
Antigens, Protozoan
/ blood
Benin
/ epidemiology
Female
Gabon
/ epidemiology
Humans
Immunoglobulin G
/ immunology
Kenya
/ epidemiology
Malaria, Falciparum
/ complications
Mozambique
/ epidemiology
Plasmodium falciparum
/ immunology
Pregnancy
Pregnancy Complications, Parasitic
/ blood
Serologic Tests
/ methods
Spain
/ epidemiology
Tanzania
/ epidemiology
Young Adult
Benin
Gabon
Kenya
Malaria
Mozambique
Plasmodium falciparum
Spain
Tanzania
VAR2CSA
exposure
immunity
parasites
pregnancy
serology
transmission
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
entrez:
21
9
2019
pubmed:
21
9
2019
medline:
15
7
2020
Statut:
ppublish
Résumé
Pregnant women constitute a promising sentinel group for continuous monitoring of malaria transmission. To identify antibody signatures of recent Plasmodium falciparum exposure during pregnancy, we dissected IgG responses against VAR2CSA, the parasite antigen that mediates placental sequestration. We used a multiplex peptide-based suspension array in 2,354 samples from pregnant women from Mozambique, Benin, Kenya, Gabon, Tanzania, and Spain. Two VAR2CSA peptides of limited polymorphism were immunogenic and targeted by IgG responses readily boosted during infection and with estimated half-lives of <2 years. Seroprevalence against these peptides reflected declines and rebounds of transmission in southern Mozambique during 2004-2012, reduced exposure associated with use of preventive measures during pregnancy, and local clusters of transmission that were missed by detection of P. falciparum infections. These data suggest that VAR2CSA serology can provide a useful adjunct for the fine-scale estimation of the malaria burden among pregnant women over time and space.
Identifiants
pubmed: 31538557
doi: 10.3201/eid2510.181177
pmc: PMC6759269
doi:
Substances chimiques
Antibodies, Protozoan
0
Antigens, Protozoan
0
Immunoglobulin G
0
VAR2CSA protein, Plasmodium falciparum
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1851-1860Références
PLoS Med. 2010 Jul 06;7(7):e1000304
pubmed: 20625549
PLoS One. 2015 Sep 22;10(9):e0137695
pubmed: 26393516
J Infect Dis. 2012 Nov 15;206(10):1612-21
pubmed: 22966126
J Immunol Res. 2015;2015:738030
pubmed: 26770994
Science. 1996 Jun 7;272(5267):1502-4
pubmed: 8633247
PLoS One. 2012;7(1):e29874
pubmed: 22299027
PLoS Pathog. 2008 Feb 8;4(2):e42
pubmed: 18282103
BMC Med. 2017 Jul 17;15(1):130
pubmed: 28712360
Placenta. 2004 May;25(5):359-78
pubmed: 15081631
BMC Med. 2017 Jun 30;15(1):121
pubmed: 28662646
Malar J. 2016 Jul 29;15(1):392
pubmed: 27473039
PLoS Med. 2014 Sep 23;11(9):e1001735
pubmed: 25247995
Sci Rep. 2014 Dec 09;4:7373
pubmed: 25487735
PLoS One. 2017 Jul 17;12(7):e0181150
pubmed: 28715465
PLoS One. 2008 Apr 09;3(4):e1934
pubmed: 18398460
Clin Vaccine Immunol. 2008 Sep;15(9):1483-4
pubmed: 18632926
J Infect Dis. 2012 Feb 15;205(4):568-77
pubmed: 22238468
Adv Parasitol. 2009;69:299-352
pubmed: 19622411
Trends Parasitol. 2014 Feb;30(2):85-94
pubmed: 24388420
Mol Microbiol. 2003 Jul;49(1):179-91
pubmed: 12823820
J Infect Dis. 2010 Jan 1;201(1):123-31
pubmed: 19954383
J Infect Dis. 2013 Jun 1;207(11):1664-74
pubmed: 23448726
Am J Trop Med Hyg. 2007 Mar;76(3):522-7
pubmed: 17360878
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
N Engl J Med. 2015 Oct 22;373(17):1607-17
pubmed: 26488692
Ann Trop Med Parasitol. 1949 Oct;43(2):117-39
pubmed: 15393585
Lancet Glob Health. 2015 Oct;3(10):e617-28
pubmed: 26296450
PLoS Med. 2014 Sep 23;11(9):e1001733
pubmed: 25247709
Mol Biochem Parasitol. 2007 Oct;155(2):103-12
pubmed: 17669514